Opicapone is a selective catechol-O-methyltransferase (COMT) inhibitor indicated as an adjunct therapy for Parkinson's disease to extend the therapeutic efficacy of levodopa. This category provides essential… Read more












Opicapone is a selective catechol-O-methyltransferase (COMT) inhibitor indicated as an adjunct therapy for Parkinson's disease to extend the therapeutic efficacy of levodopa. This category provides essential materials for rigorous pharmaceutical analysis, including Opicapone reference standards, its known impurities, related metabolites such as glucuronides and sulfates, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for impurity profiling, method validation, and routine quality control testing. By incorporating these reference standards, researchers can effectively identify and quantify degradation products formed under various stress conditions—such as hydrolysis or oxidation—and ensure compliance with regulatory standards. Furthermore, stable isotope labelled compounds serve as critical internal standards for bioanalytical studies, enabling precise quantification in complex biological matrices throughout the drug development and manufacturing lifecycle.